The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells

Journal of Leukocyte Biology

Volumn 94, Issue 5, 2013, Pages 865-875

  Nündel, Kerstin ^a,b   Busto, Patricia ^a,b   Debatis, Michelle ^a,b   Marshak Rothstein, Ann ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Auto reactive B cells; Autoantibody; Btk; Marginal zone B cells; Toll like receptor; Xid

Indexed keywords

BRUTON TYROSINE KINASE; DNA; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M ANTIBODY; RHEUMATOID FACTOR; RNA; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

AUTOANTIBODY; AUTOREACTIVE B CELLS; BTK; MARGINAL ZONE B CELLS; TOLL-LIKE RECEPTOR; XID;

ANIMALS; B-LYMPHOCYTES; FEMALE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, TRANSGENIC; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL; RHEUMATOID FACTOR; TOLL-LIKE RECEPTORS;

EID: 84887001547     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0313126     Document Type: Article

References (42)

1. Takata, M., Kurosaki, T. (1996) A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-2. J. Exp. Med. 184, 31-40.
2. Dye, J. R., Palvanov, A., Guo, B., Rothstein, T. L. (2007) B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-B activation. J. Immunol. 179, 229-235.
3. Mizuno, T., Rothstein, T. L. (2003) Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-B. J. Immunol. 170, 2806-2810.
4. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Sh-lomchik, M. J., Marshak-Rothstein, A. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607.
5. Jefferies, C. A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., O'Neill, L. A. (2003) Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor B activation by Toll-like receptor 4. J. Biol. Chem. 278, 26258-26264.
6. Hannum, L. G., Ni, D., Haberman, A. M., Weigert, M. G., Shlomchik, M. J. (1996) A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med. 184, 1269-1278.
7. Wolfowicz, C. B., Sakorafas, P., Rothstein, T. L., Marshak-Rothstein, A. (1988) Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice. Clin. Immunol. Immunopathol. 46, 382-395.
8. Shlomchik, M. J., Zharhary, D., Saunders, T., Camper, S. A., Weigert, M. G. (1993) A rheumatoid factor transgenic mouse model of autoantibody regulation. Int. Immunol. 5, 1329-1341.
9. Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., Marshak-Rothstein, A. (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202, 1171-1177.
10. Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., Marshak-Rothstein, A. (2003) Activation of autoreactive B cells by CpG dsDNA. Immunity 19, 837-847.
11. Prak, E. L., Weigert, M. (1995) Light chain replacement: a new model for antibody gene rearrangement. J. Exp. Med. 182, 541-548.
12. Sweet, R. A., Christensen, S. R., Harris, M. L., Shupe, J., Sutherland, J. L., Shlomchik, M. J. (2010) A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation. Autoimmunity 43, 607-618.
13. Green, N. M., Moody, K. S., Debatis, M., Marshak-Rothstein, A. (2012) Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands. J. Biol. Chem. 287, 39789-39799.
14. Sidman, C. L., Shultz, L. D., Hardy, R. R., Hayakawa, K., Herzenberg, L. A. (1986) Production of immunoglobulin isotypes by Ly-1 B cells in viable motheaten and normal mice. Science 232, 1423-1425.
15. Chen, X., Martin, F., Forbush, K. A., Perlmutter, R. M., Kearney, J. F. (1997) Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9, 27-41.
16. Wen, L., Brill-Dashoff, J., Shinton, S. A., Asano, M., Hardy, R. R., Hay-akawa, K. (2005) Evidence of marginal-zone B cell-positive selection in spleen. Immunity 23, 297-308.
17. Srivastava, B., Quinn III W. J., Hazard, K., Erikson, J., Allman, D. (2005) Characterization of marginal zone B cell precursors. J. Exp. Med. 202, 1225-1234.
18. De Weers, M., Verschuren, M. C., Kraakman, M. E., Mensink, R. G., Schuurman, R. K., van Dongen, J. J., Hendriks, R. W. (1993) The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur. J. Immunol. 23, 3109-3114.
19. Janeway C. A., Jr., Barthold, D. R. (1975) An analysis of the defective response of CBA/N mice to T-dependent antigens. J. Immunol. 115, 898-900.
20. Scher, I., Ahmed, A., Strong, D. M., Steinberg, A. D., Paul, W. E. (1975) X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J. Exp. Med. 141, 788-803.
21. Hardy, R. R., Hayakawa, K., Parks, D. R., Herzenberg, L. A. (1983) Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence. Nature 306, 270-272.
22. Hayakawa, K., Hardy, R. R., Herzenberg, L. A. (1986) Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased light chain expression. Eur. J. Immunol. 16, 450-456.
23. Sieckmann, D. G., Asofsky, R., Mosier, D. E., Zitron, I. M., Paul, W. E. (1978) Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J. Exp. Med. 147, 814-829.
24. Chan, V. W., Mecklenbrauker, I., Su, I., Texido, G., Leitges, M., Carsetti, R., Lowell, C. A., Rajewsky, K., Miyake, K., Tarakhovsky, A. (1998) The molecular mechanism of B cell activation by Toll-like receptor protein RP-105. J. Exp. Med. 188, 93-101.
25. Lund, F. E., Yu, N., Kim, K. M., Reth, M., Howard, M. C. (1996) Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J. Immunol. 157, 1455-1467.
26. Lee, K. G., Xu, S., Wong, E. T., Tergaonkar, V., Lam, K. P. (2008) Bruton's tyrosine kinase separately regulates NFB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B cells. J. Biol. Chem. 283, 11189-11198.
27. Woodland, R. T., Schmidt, M. R., Korsmeyer, S. J., Gravel, K. A. (1996) Regulation of B cell survival in Xid mice by the proto-oncogene bcl-2. J. Immunol. 156, 2143-2154.
28. Shinners, N. P., Carlesso, G., Castro, I., Hoek, K. L., Corn, R. A., Woodland, R. T., Scott, M. L., Wang, D., Khan, W. N. (2007) Bruton's tyrosine kinase mediates NF-B activation and B cell survival by B cell-activating factor receptor of the TNF-R family. J. Immunol. 179, 3872-3880.
29. Cariappa, A., Tang, M., Parng, C., Nebelitskiy, E., Carroll, M., Georgo-poulos, K., Pillai, S. (2001) The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, btk, and CD21. Immunity 14, 603-615.
30. Martin, F., Kearney, J. F. (2000) Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12, 39-49.
31. Halcomb, K. E., Musuka, S., Gutierrez, T., Wright, H. L., Satterthwaite, A. B. (2008) Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells. Mol. Immunol. 46, 233-241.
32. Dingjan, G. M., Middendorp, S., Dahlenborg, K., Maas, A., Grosveld, F., Hendriks, R. W. (2001) Bruton's tyrosine kinase regulates the activation of gene rearrangements at the light chain locus in precursor B cells in the mouse. J. Exp. Med. 193, 1169-1178.
33. Perlmutter, R. M., Nahm, M., Stein, K. E., Slack, J., Zitron, I., Paul, W. E., Davie, J. M. (1979) Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J. Exp. Med. 149, 993-998.
34. He, B., Santamaria, R., Xu, W., Cols, M., Chen, K., Puga, I., Shan, M., Xiong, H., Bussel, J. B., Chiu, A., Puel, A., Reichenbach, J., Marodi, L., Doffinger, R., Vasconcelos, J., Issekutz, A., Krause, J., Davies, G., Li, X., Grimbacher, B., Plebani, A., Meffre, E., Picard, C., Cunningham-Rundles, C., Casanova, J. L., Cerutti, A. (2010) The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat. Immunol. 11, 836-845.
35. Casola, S., Otipoby, K. L., Alimzhanov, M., Humme, S., Uyttersprot, N., Kutok, J. L., Carroll, M. C., Rajewsky, K. (2004) B cell receptor signal strength determines B cell fate. Nat. Immunol. 5, 317-327.
36. Bos, N. A., Kimura, H., Meeuwsen, C. G., De Visser, H., Hazenberg, M. P., Wostmann, B. S., Pleasants, J. R., Benner, R., Marcus, D. M. (1989) Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur. J. Immunol. 19, 2335-2339.
37. Amsbaugh, D. F., Hansen, C. T., Prescott, B., Stashak, P. W., Barthold, D. R., Baker, P. J. (1972) Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J. Exp. Med. 136, 931-949.
38. Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I., Rathbun, G., Davidson, L., Muller, S., Kantor, A. B., Herzenberg, L. A., et al. (1995) Defective B cell development and function in btk-deficient mice. Immunity 3, 283-299.
39. Scher, I., Steinberg, A. D., Berning, A. K., Paul, W. E. (1975) X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J. Exp. Med. 142, 637-650.
40. Guo, B., Rothstein, T. L. (2005) B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent. J. Immunol. 174, 5375-5381.
41. Gray, P., Dunne, A., Brikos, C., Jefferies, C. A., Doyle, S. L., O'Neill, L. A. (2006) MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J. Biol. Chem. 281, 10489-10495.
42. Steinberg, E. B., Santoro, T. J., Chused, T. M., Smathers, P. A., Steinberg, A. D. (1983) Studies of congenic MRL-lpr/lpr.xid mice. J. Immunol. 131, 2789-2795.